EverSource Wealth Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.3K Buy
28
+2
+8% +$279 ﹤0.01% 3454
2025
Q4
$4.26K Buy
26
+14
+117% +$2.19K ﹤0.01% 3189
2025
Q3
$1.6K Sell
12
-6
-33% -$729 ﹤0.01% 3586
2025
Q2
$2.24K Sell
18
-20
-53% -$2.54K ﹤0.01% 3476
2025
Q1
$4.83K Buy
38
+7
+23% +$1.08K ﹤0.01% 2511
2024
Q4
$4.46K Buy
31
+17
+121% +$2.44K ﹤0.01% 2401
2024
Q3
$2.08K Buy
14
+4
+40% +$574 ﹤0.01% 2537
2024
Q2
$1.67K Sell
10
-27
-73% -$4.23K ﹤0.01% 2607
2024
Q1
$6.08K Buy
37
+29
+363% +$5.52K ﹤0.01% 1953
2023
Q4
$1.44K Sell
8
-31
-79% -$4.83K ﹤0.01% 2280
2023
Q3
$6.2K Buy
39
+32
+457% +$5.23K ﹤0.01% 1616
2023
Q2
$990 Buy
+7
New +$1.12K ﹤0.01% 2235
2022
Q1
Sell
-6
Closed -$2K 1820
2021
Q4
$2K Buy
+6
New +$1.62K ﹤0.01% 1608

Other funds holding RGEN

EverSource Wealth Advisors's RGEN Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Repligen (RGEN) stake by 7.7% in Q1 2026, buying an estimated $279 and bringing the position to 28 shares worth $3.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3454.

EverSource Wealth Advisors first reported a position in RGEN in Q4 2021 and has held it in 13 quarters since. The position peaked at $6.2K in Q3 2023. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • EverSource Wealth Advisors held 28 shares of Repligen worth $3.3K as of Q1 2026.
  • EverSource Wealth Advisors bought 2 Repligen shares in Q1 2026, an estimated $279.
  • Repligen made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3454 holding.
  • EverSource Wealth Advisors first reported a position in Repligen in Q4 2021 and has held it in 13 quarters since.
  • EverSource Wealth Advisors's Repligen position peaked at $6.2K in Q3 2023.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.